Vascular biology of uterine fibroids: connecting fibroids and vascular disorders
Affiliations
Affiliations
- Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Obstetrics and Gynecology, Kuwait University, Kuwait City, Kuwait.
Abstract
Fibroids are benign tumors caused by the proliferation of myometrial smooth muscle cells in the uterus that can lead to symptoms such as abdominal pain, constipation, urinary retention, and infertility. While traditionally thought of as a disease process intrinsic to the uterus, accumulating evidence suggests that fibroid growth may be linked with the systemic vasculature system, although cell-intrinsic factors are certainly of principal importance in their inception. Fibroids are associated with essential hypertension and preeclampsia, as well as atherosclerosis, for reasons that are becoming increasingly elucidated. Factors such as the renin-angiotensin-aldosterone system, estrogen, and endothelial dysfunction all likely play a role in fibroid pathogenesis. In this review, we lay out a framework for reconceptualizing fibroids as a systemic vascular disorder, and discuss how pharmaceutical agents and other interventions targeting the vasculature may aid in the novel treatment of fibroids.
Conflict of interest statement
Conflict of interest statement: The authors have no conflicts of interest to declare.
Similar articles
The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.
Tal R, Segars JH.Hum Reprod Update. 2014 Mar-Apr;20(2):194-216. doi: 10.1093/humupd/dmt042. Epub 2013 Sep 29.PMID: 24077979 Free PMC article. Review.
The management of uterine leiomyomas.
Vilos GA, Allaire C, Laberge PY, Leyland N; SPECIAL CONTRIBUTORS.J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8.PMID: 25767949
The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B, Havelock J, Hemmings R; REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE; SPECIAL CONTRIBUTOR.J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2.PMID: 26001875
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A, Whitaker L, Chow TL, Sobel ML.Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD010770. doi: 10.1002/14651858.CD010770.pub2.PMID: 28444736 Free PMC article. Review.
Segars JH, Parrott EC, Nagel JD, Guo XC, Gao X, Birnbaum LS, Pinn VW, Dixon D.Hum Reprod Update. 2014 May-Jun;20(3):309-33. doi: 10.1093/humupd/dmt058. Epub 2014 Jan 8.PMID: 24401287 Free PMC article.
Cited by
Abu-Zaid A, Alrashidi H, Almouh A, Abualsaud ZM, Saleh AM, Aldawsari SB, Alajmi MM, Alomar O.Cureus. 2022 Nov 16;14(11):e31571. doi: 10.7759/cureus.31571. eCollection 2022 Nov.PMID: 36540502 Free PMC article. Review.
Management of Uterine Fibroids and Its Complications During Pregnancy: A Review of Literature.
Datir SG, Bhake A.Cureus. 2022 Nov 4;14(11):e31080. doi: 10.7759/cureus.31080. eCollection 2022 Nov.PMID: 36475121 Free PMC article. Review.
Harvey RE, Laughlin-Tommaso SK, Stewart EA, Limberg JK, Curry TB, Joyner MJ, Barnes JN.Physiol Rep. 2022 Sep;10(18):e15445. doi: 10.14814/phy2.15445.PMID: 36117415 Free PMC article.
Advances in the clinical application of ultrasound elastography in uterine imaging.
Wang XL, Lin S, Lyu GR.Insights Imaging. 2022 Sep 4;13(1):141. doi: 10.1186/s13244-022-01274-9.PMID: 36057675 Free PMC article. Review.
References
https://pubmed.ncbi.nlm.nih.gov/